Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line-Reference-Cited by-同舟云学术

Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line

Published:2006-10 Issue:7 Volume:33 Page:875-882
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Jeong Hwanjeong,Kim Yu-Ri,Kim Ki-Nam,Choe Jae-Gol,Chung June-Key,Kim Meyoung-Kon

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference46 articles.

1. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids;Haugen;J Clin Endocrinol Metab,2004

2. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells;Dentice;Mol Cell Biol,2004

3. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene;Lee;Thyroid,2004

4. Medical therapy for differentiated thyroid carcinoma;Dulgeroff;Endocr Rev,1994

5. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells;Schmutzler;Biochem Biophys Res Commun,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks;Archives of Biochemistry and Biophysics;2022-01

2. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS;Theranostics;2021

3. An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer;European Journal of Medicinal Chemistry;2020-11

4. Redifferentiation of radioiodine-refractory thyroid cancers;Endocrine-Related Cancer;2020-05

5. The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma;International Journal of Molecular Sciences;2018-02-26